Impact of GLP-1 Receptor Agonists on Suicide Behavior: A Meta-Analysis Based on Randomized Controlled Trials.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Impact of GLP-1 Receptor Agonists on Suicide Behavior: A Meta-Analysis Based on Randomized Controlled Trials.
- Published In:
- Journal of diabetes, 17(9), e70151 (2025)
- Authors:
- Chen, Jingqi, Zhang, Qiufeng, Wu, Qingping, Zhang, Xiaoming, Xiang, Zhiyi, Zhu, Sidong, Dai, Tianfu, Si, Yuexiu
- Database ID:
- RPEP-10391
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10391APA
Chen, Jingqi; Zhang, Qiufeng; Wu, Qingping; Zhang, Xiaoming; Xiang, Zhiyi; Zhu, Sidong; Dai, Tianfu; Si, Yuexiu. (2025). Impact of GLP-1 Receptor Agonists on Suicide Behavior: A Meta-Analysis Based on Randomized Controlled Trials.. Journal of diabetes, 17(9), e70151. https://doi.org/10.1111/1753-0407.70151
MLA
Chen, Jingqi, et al. "Impact of GLP-1 Receptor Agonists on Suicide Behavior: A Meta-Analysis Based on Randomized Controlled Trials.." Journal of diabetes, 2025. https://doi.org/10.1111/1753-0407.70151
RethinkPeptides
RethinkPeptides Research Database. "Impact of GLP-1 Receptor Agonists on Suicide Behavior: A Met..." RPEP-10391. Retrieved from https://rethinkpeptides.com/research/chen-2025-impact-of-glp1-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.